STOCK TITAN

McKesson Corp (MCK) director Bradley Lerman reports sale of 301 shares

(Moderate)
(Negative)
Form Type
4

Rhea-AI Filing Summary

McKesson Corp director Bradley E. Lerman reported a sale of 301 shares of Common Stock on 2026-08-10 in a sale in open market or private transaction at $892.325 per share. Following this transaction, his reported direct holdings of McKesson common stock are 0 shares.

Positive

  • None.

Negative

  • None.
Insider Lerman Bradley E
Role Director
Sold 301 shs ($269K)
Type Security Shares Price Value
Sale Common Stock 301 $892.325 $269K
Holdings After Transaction: Common Stock — 0 shares (Direct)
Shares sold 301 shares Common Stock sale on 2026-08-10 by director Bradley E. Lerman
Sale price per share $892.325 Price per share for the 301-share Common Stock sale
Shares held after transaction 0 shares Direct ownership of McKesson common stock after the reported sale

FAQ

What insider transaction did MCK director Bradley E. Lerman report?

Bradley E. Lerman reported a sale of 301 shares of McKesson Corp (MCK) common stock on 2026-08-10 at $892.325 per share, in an open market or private transaction.

How many McKesson (MCK) shares did Bradley E. Lerman sell and at what price?

He sold 301 shares of McKesson common stock at a price of $892.325 per share. The transaction was reported as a sale in an open market or private transaction.

What are Bradley E. Lerman’s McKesson (MCK) holdings after this Form 4 sale?

After the reported sale, Bradley E. Lerman’s direct holdings are 0 shares of McKesson common stock, according to the post-transaction ownership reported in the Form 4.

Was the McKesson (MCK) insider sale by Bradley E. Lerman under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirmatively adopted. The transaction is described simply as a sale in an open market or private transaction, with no additional plan-related footnote detail provided.

What is the total number of McKesson (MCK) shares sold by Bradley E. Lerman in this Form 4?

This Form 4 reports a single sale of 301 shares of McKesson common stock by Bradley E. Lerman. No other share purchases, sales, or derivative exercises are included in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lerman Bradley E

(Last)(First)(Middle)
6555 STATE HWY 161

(Street)
IRVING TEXAS 75039

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MCKESSON CORP [ MCK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/10/2026S301D$892.3250D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Sarah Ahmad Ali, Attorney-in-fact08/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)